Canon USA Invests in Spartan Bioscience | GenomeWeb

NEW YORK (GenomeWeb) – Canon USA said today that it has made a strategic investment in Canada's Spartan Bioscience to help fund the research and development of new diagnostic testing products.

Canon BioMedical, the recently established wholly owned subsidiary of Canon USA, plans to work with Spartan to develop future diagnostic products, including rapid genetic testing, Canon said.

Financial details of the investment were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.